Lv512
1320 积分 2024-10-12 加入
Lipoprotein(a) and its Significance in Cardiovascular Disease
3个月前
已完结
Effect of Nicotinic acid/Laropiprant in the lipoprotein(a) concentration with regard to baseline lipoprotein(a) concentration and LPA genotype
3个月前
已关闭
Role of lipoprotein(a) in atherosclerotic cardiovascular disease: A review of current and emerging therapies
4个月前
已完结
PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the future
4个月前
已完结
PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a)
4个月前
已完结
PCSK9 inhibition with alirocumab decreases plasma lipoprotein(a) concentration by a dual mechanism of action in statin‐treated patients with very high apolipoprotein(a) concentration
4个月前
已完结
Lipoprotein(a) in atherosclerotic cardiovascular disease and proprotein convertase subtilisin/kexin-type 9 inhibitors
4个月前
已完结
Percutaneous Coronary Intervention vs Coronary Artery Bypass Graft Surgery for Left Main Disease in Patients With and Without Acute Coronary Syndromes
6个月前
已完结
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction
1年前
已完结
Thyroid hormones and cardiovascular disease
1年前
已完结
皖公网安备34019202002308
